Opexa Therapeutics, Inc. (OPXA) Reports Q3 Loss of $0.06
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Price: $0.97 --0%
Financial Fact:
Other income and expense, net: -2.38K
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Other income and expense, net: -2.38K
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
Opexa Therapeutics, Inc. (NASDAQ: OPXA) reported Q3 EPS of ($0.06), versus ($0.07) reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Greenlane Holdings Inc. (GNLN) reported Q2 result
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
